Verition Fund Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,371
Closed -$45K 2964
2022
Q3
$45K Hold
15,371
﹤0.01% 2702
2022
Q2
$69K Buy
+15,371
New +$91.5K ﹤0.01% 2116

Other funds holding SLGC

Verition Fund Management's SLGC Position: Q4 2022 in Review

Verition Fund Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2022, closing a stake of 15,371 shares — an estimated $45K sold.

Verition Fund Management first reported a position in SLGC in Q2 2022 and held it in 2 quarters. The position peaked at $69K in Q2 2022. 140 funds tracked by Wall St. Rank hold SLGC as of Q4 2022.

  • Verition Fund Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 15,371 SomaLogic, Inc. Class A Common Stock shares in Q4 2022, an estimated $45K.
  • Verition Fund Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Verition Fund Management's SomaLogic, Inc. Class A Common Stock position peaked at $69K in Q2 2022.
  • 140 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.